Huperzine A for memory problems after brain aneurysm treatment
Part of Brain & nervous system clinical trials.
This study tests an investigational drug called Huperzine A, given as an injection after treatment for a bleeding brain aneurysm, to see if it can help prevent or reduce thinking and memory problems that sometimes occur after surgery or procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You had a bleeding aneurysm in the brain, confirmed by imaging (like a CT scan, CTA, or DSA).
- You had treatment (such as coiling or clipping) within 72 hours of the bleeding starting.
- You did not have memory or thinking problems before this event.
- You are not taking other dementia medications like donepezil or rivastigmine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether huperzine A can improve hearing-related symptoms along with tinnitus (ringing) and mild cognitive (memory/thinking) problems. If you have mild-to-moderate hearing loss plus bothersome constant tinnitus and some cognitive decline, this study may help researchers see if the treatment makes a difference.
This study tests a natural compound called beta-sitosterol (from Gastrodia elata) to see if it can help people recover better after a brain aneurysm bleed. You must have had your aneurysm treated within 48 hours and be in relatively stable condition.
This study tests if a surgical treatment that improves brain waste drainage, combined with the standard Alzheimer's drug donepezil, works better than the drug alone. It is for people with mild-to-moderate Alzheimer's dementia.
This trial studies whether a medicine called huperzine A can reduce “postoperative delirium,” which is sudden confusion after surgery, in older adults. It focuses on people having non-heart surgery under general anesthesia for at least two hours.
This trial studies how the body processes a liquid form of huperzine A, a natural compound that may help memory and thinking, in healthy adults. By participating, you help researchers understand how the drug is absorbed and cleared from the body, which is important for future use.
This study tests whether Huperzine A controlled-release tablets can help improve memory and thinking in people with mild-to-moderate Alzheimer's disease. You'll take the tablets or a placebo to see if it slows down dementia symptoms.
Hear when a new Postoperative Cognitive Dysfunction in Patients With Aneurysmal Subarachnoid Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.